Arcturus Therapeutics Holdings Inc (NAS:ARCT)
$ 18.36 -0.47 (-2.5%) Market Cap: 497.32 Mil Enterprise Value: 302.30 Mil PE Ratio: 0 PB Ratio: 1.90 GF Score: 76/100

Q1 2024 Arcturus Therapeutics Holdings Inc Earnings Call Transcript

May 08, 2024 / 08:30PM GMT
Release Date Price: $27.21 (-1.27%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the Arcturus Therapeutics First Quarter 2024 earnings call. At this time, all lines are in listen only mode. Following the presentation, we will conduct a question and answer session. (Operator Instructions) This call is being recorded on Wednesday, May 8, 2024. I would now like to turn the conference over to meta so far Zeta Vice President, Head of Investor Relations, Public Relations and Marketing of Arcturus Therapeutics. Please go ahead.

Neda Safarzadeh
Arcturus Therapeutics Holdings, Inc. - Vice President and Head of IR, Public Relations, and Marketing

Thank you, operator, and good afternoon, and welcome to Arcturus Therapeutics quarterly financial update and pipeline progress call. today's call will be led by Joe Payne, our President and CEO; and Andy Sassine, our CFO; Dr. Padmanabh Chivukula, our CSO and COO, will join them for the Q&A session. Before we begin, I would like to remind everyone that statements made during this call regarding matters that are not historical facts are forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot